Hank BondWalther

Partner

(T) + 1.202.879.3432

As a former federal prosecutor who led large, complex criminal fraud and corruption cases at the Department of Justice, Hank Walther often handles sensitive U.S. and multijurisdiction matters that could significantly impact a company's health and reputation. He is an accomplished investigator and trial lawyer with significant experience investigating and defending health care fraud, Foreign Corrupt Practices Act, securities fraud, False Claims Act, and other financial fraud, antitrust, and corruption matters. Hank has been recognized as one of the top white collar lawyers in the country by Chambers USA and Super Lawyers and Who's Who Legal named him as one of the three "Most Highly Regarded" attorneys in the U.S. under age 45 in the investigations field.

Hank often defends companies that are facing criminal prosecution and civil liability from numerous government agencies and civil litigants in multiple countries. In these matters, he works closely with clients to coordinate criminal defense and civil litigation strategies that will most effectively represent the clients' various interests around the world. Hank has led fraud and corruption investigations in the U.S. and 30 other countries, including Brazil, Cameroon, Canada, China, Ecuador, France, Germany, Ghana, India, Indonesia, Iraq, Israel, Italy, Mexico, Nigeria, Peru, Philippines, Qatar, Romania, Russia, Saudi Arabia, Slovakia, South Africa, Spain, Taiwan, Tanzania, Thailand, Turkey, the United Kingdom, and Venezuela.

Hank has been published and quoted by numerous publications, including the New York Times, Wall Street Journal, Washington Post, and Financial Times.

Experience

  • Former CEO defends allegations of fraud and sanctions laws violationsJones Day is defending the former CEO of an international logistic company charged with violating Iran sanctions laws and engaging in a multibillion dollar fraud scheme.
  • Global financial institution conducts internal investigation into allegations of foreign currency exchange rate manipulation in multiple countries and defends related DOJ Antitrust Division investigationJones Day is representing a global financial institution in an internal investigation into allegations of foreign currency exchange rate manipulation in multiple countries and a related DOJ Antitrust Division investigation.
  • National retailer defends allegations of corruption in Latin America and AsiaJones Day is representing a national retailer in an internal investigation into allegations of corruption in multiple countries in Latin America and Asia and related DOJ and SEC investigations.
  • Jones Day advises on UK's first Deferred Prosecution Agreement and closure of U.S. DOJ investigationOn Monday, November 30, 2015, the Right Honourable Sir Brian Leveson (the President of the Queen's Bench Division) approved the resolution of the first UK Bribery Act section 7 proceedings by way of a Deferred Prosecution Agreement, a procedure never before used in the UK.
  • Oil and gas company conducts internal investigation into allegations of corruption in AsiaJones Day represented a publicly-traded oil and gas company in an internal investigation into allegations of corruption in Asia.
  • Medical device company conducts internal investigation into allegations of off-label marketingJones Day represented a publicly-traded medical device company in an internal investigation into allegations of off-label marketing.
  • Executive of manufacturing company defends allegations of corruption in AsiaJones Day represented an executive from a global manufacturing company in a DOJ investigation into allegations of corruption in Asia.
  • Owner of medical supply company defends allegations of health care kickbacksJones Day represented an owner of a medical supply company in a Health and Human Services investigation into allegations of health care kickbacks.
  • National law firm defends allegations of money launderingJones Day represented a national law firm in an investigation into allegations of money laundering.
  • Technology company conducts internal investigation into allegations of corruption in Eastern EuropeJones Day represented a publicly-traded technology company in an internal investigation into allegations of corruption in Eastern Europe.
  • Executive of medical device company defends allegations of corruption in Latin AmericaJones Day represented an executive from a publicly-traded medical device company in a DOJ and SEC investigation into allegations of corruption in Latin America.
  • Hospital system successfully resolves false claims for transport servicesJones Day represented a hospital system in a False Claims Act investigation into false claims for transport services.
  • Speaking Engagements

    • September 27, 2017
      PLI's Storming the Gatekeepers: When Compliance Officers and In-House Lawyers Are at Risk 2017
    • April 20, 2017
      The State of the Union: FCPA Enforcement in a Trump Administration, 19th Annual New York Conference on the Foreign Corrupt Practices Act, American Conference Institute
    • January 12, 2017
      The FCPA’s Jurisdictional Hooks – How Far Do They Reach, Who Can They Ensnare?, Eleventh Annual National Institute on Securities Fraud, American Bar Association
    • September 21, 2016
      The French Anti-corruption Bill / Loi Sapin II – Crossed Views: France – United States
    • September 21, 2016
      Sapin ll and International Anti-Corruption Developments
    • 21 septembre 2016
      Loi Sapin II : Anti-corruption - Regards croisés France - Etats-Unis
    • February 9, 2016
      First Deferred Prosecution in the UK, US Department of Justice agrees to close investigation
    • December 1, 2015
      Anti-Corruption Congress
    • May 14-15, 2015
      2015 Health Care Labor & Employment Symposium
    • September 26, 2013
      Executive Roundtable Series - Responding to a Government Investigation: Defending the Company and Its People and Protecting Its Reputation
    • April 9-10, 2013
      Jones Day 2013 Chicago Health Care Conference
    • May 8-9, 2012
      FCPA and Anti-Corruption for the Life Sciences Industry 6th National Conference
    • April 19, 2012
      Qui Tam Litigation: When Private Parties Pursue Claims for the Government
    • March 28, 2012
      Health Care 2012: Issues and Answers for a Complex Industry
    • March 28, 2012
      Healthcare 2012: Issues & Answers For A Complex Industry
    • March 15-16, 2012
      Global Ethics Summit 2012, Thomson Reuters and the Ethisphere Institute
    • November 16, 2011
      Medicare Fraud Strike Force: 2011 and Beyond, National Health Care Anti-Fraud Association, Annual Training Conference
    • November 15, 2011
      Law Enforcement Strategies, Global Health Care Anti-Fraud Network, Global Health Care Fraud Prevention Summit
    • May 12, 2011
      Government Enforcement Panel, American Bar Association, 21st National Institute on Health Care Fraud
    • January 25, 2011
      Understanding the Department of Justice’s Enforcement Priorities: Steering Clear of Criminal and Civil Liability When Conducting Clinical Trials, American Conference Institute, Advanced Forum on Clinical Trials
    • January 24, 2011
      Trends in Enforcement: Areas of Focus for State and Federal Prosecutors, Center for Business Intelligence, Pharmaceutical Compliance Conference
    • December 7, 2010
      Enforcement and Compliance Roundtable, American Bar Association, Washington Healthcare Summit
    • November 17, 2010
      Medicare Fraud Strike Force: 2010 and Beyond, National Health Care Anti-Fraud Association, Annual Training Conference
    • August 5, 2010
      The Shift in Focus to Individuals in FCPA Prosecutions, American Bar Association, 2010 Annual Meeting
    • June 28, 2010
      HEAT Anti-Fraud Initiative – Florida: Come for the Fraud and Stay for the HEAT, American Health Lawyer’s Association, 2010 Annual Meeting
    • June 23, 2010
      Personal Liability: How the Shift Towards Individual Prosecution Will Affect You and Minimize FCPA Risks Before, During, and After M&A, Ethical Corporation 3rd Annual Global Anti-Corruption Summit USA
    • May 18, 2010
      U.S. and International FCPA and Anti-Corruption Enforcement Priorities, American Conference Institute, FCPA and Anti-Corruption for Life Science Companies Conference
    • May 14, 2010
      Trial Practice Demonstration: United States v. Valladares, American Bar Association, 20th National Institute on Health Care Fraud
    • March 23, 2010
      Structuring Cost-Efficient Internal Investigations of Improper Payments, American Conference Institute, National Conference on the Foreign Corrupt Practices Act
    • February 23, 2010
      When the Government Comes Knocking, Ethisphere Global Ethics Summit
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.